Renal interstitial fibrosis is considered the final common pathway of progressive kidney disease leading to end-stage renal failure. [1] [2] [3] It is characterized histopathologically by loss of renal tubules, increased number of myofibroblasts, and accumulation of extracellular matrix (ECM). [4] [5] [6] Recent studies have emphasized the potential role of epithelial-tomesenchymal transition (EMT) in the development of renal interstitial fibrosis. [7] [8] [9] [10] [11] [12] Tubular epithelial cells can acquire a mesenchymal phenotype after several injuries, enhance migratory capacity enabling them to transit from the renal tubular microenvironment into the interstitial space, and contribute to the development of renal fibrosis as ECMproducing myofibroblasts. The role of EMT in renal fibrogenesis has been suggested in several studies of cultured cells, animal models of kidney diseases, and human nephropathies and kidney transplantation, [7] [8] [9] [10] [11] [12] although several recent studies also demonstrate the doubt on this mechanism as a major contributor to renal fibrosis. [13] [14] [15] Matrix metalloproteinases (MMPs) are a family of zincdependent proteases responsible for ECM turnover as well as degradation of bioactive proteins. [16] [17] [18] This family includes collagenases, gelatinases, stromelysins, and membrane-type MMPs. In the EMT sites during renal fibrogenesis, MMPs mediate disruption of the integrity of the tubular basement membrane (TBM), which in turn promotes tubular epithelial cell EMT, and progressive interstitial fibrosis. [19] [20] [21] Recent studies have demonstrated that MMPs, especially gelatinases (MMP-2 and MMP-9) have major roles in the EMT process, and are involved in the renal tubular cell EMT both in vivo and in vitro. Although specific therapies that inhibit the progression of chronic renal disease are currently not available, modulation of MMPs in the EMT seems a legitimate therapeutic target with the aim of inhibition of renal fibrogenesis. With regard to MMP-9, a recent study demonstrated that mice lacking the MMP-9 gene show mild renal interstitial fibrosis in unilateral ureteral obstruction (UUO). 22 However, the therapeutic effect of MMP-2 inhibition on progressive renal fibrosis is still uncertain.
This study was designed to determine the involvement of MMP-2 during the development of renal fibrosis in a UUO model. UUO is a well-established experimental model of renal injury leading to progressive interstitial fibrosis. 23, 24 After demonstrating the activation of MMP-2, experiments were performed to determine the therapeutic effects of MMP inhibition on progressive renal fibrosis, in both MMP-2 knockout (MMP-2 À/À ) mice and mice treated with minocycline, a MMP inhibitor.
MATERIALS AND METHODS Mice

MMP-2
À/À mice generated in C57BL/6 genetic background by gene targeting were kindly provided by Shigeyoshi Itohara (Laboratory for Behavioral Genetics, RIKEN Brain Science Institute, Saitama, Japan). 25 All experimental procedures described here were approved by the Nippon Medical School Animal Studies Committee.
Renal UUO Model
Three experiments were performed in this study using 12-week-old male MMP-2 wild-type (MMP-2 þ / þ ) and MMP-2 À/À mice. In experiment 1, renal interstitial fibrosis was induced in MMP-2 þ / þ mice by UUO operation, using the same procedures described previously. 23, 24 After the induction of general anesthesia by intraperitoneal (IP) injection of pentobarbital (40-70 mg/kg body wt), the mice were subjected to either UUO or sham operation. In UUO animals, the lower 1/3 portion of left ureter between the kidney and the bladder was identified through a small suprapubic incision and was ligated with 4-0 silk at two points and cut between the ligatures in order to prevent retrograde urinary tract infection. The sham operation consisted of a similar suprapubic incision and identification of the left ureter, but no ligation of the ureter was performed. These animals were used to obtain control kidneys. After UUO/sham operation, the mice (n ¼ 5 at each time point) were killed at 3, 5, 7, 10, and 14 days after operation. Experiment 2 involved exactly the same UUO or sham operation but was performed in MMP-2 À/À mice. The mice (n ¼ 5 at each time point) were killed at 3, 5, 7, 10, and 14 days after operation. In experiment 3, MMP-2 þ / þ mice with UUO were treated with minocycline (Sigma, St Louis, MO, USA) as MMP-2 and MMP-9 inhibitor, from 36 h before to 14 days post-UUO. Minocycline 45 mg/kg in dimethyl sulfoxide (DMSO) and 0.9% NaCl or an equal volume of DMSO and 0.9% NaCl (placebo) was injected IP at 36 h before renal UUO and was followed by 22.5 mg/kg minocycline or placebo IP every 12 h for 14 days post-UUO, based on the protocol described previously. 26 Mice (n ¼ 5 at each time point) treated with minocycline were killed at days 5 and 14.
Histopathological, Immunohistochemical, and Electron Microscopic Examinations
The left kidneys harvested from the UUO and sham-operated animals were fixed in 20% buffered formalin and embedded in paraffin for light microscopy. Tissues were stained with hematoxylin and eosin, periodic acid-Schiff, Masson trichrome (Masson), and periodic acid-methenamine Silver for histopathological examination.
The following primary antibodies were used for immunohistochemistry: (a) goat polyclonal anti-MMP-2 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) to detect MMP-2-producing cells, (b) goat polyclonal anti-MMP-9 (Santa Cruz Biotechnology) to detect MMP-9-producing cells, (c) rabbit polyclonal anti-S100A4 (Thermo Scientific, Middletown, VA, USA), also known as fibroblast-specific protein 1 and thought to be a marker of the mesenchymal cells, (d) mouse monoclonal anti-vimentin (M851; Dako, Glostrup, Denmark), an intermediate filament protein expressed only in mesenchymal cells, (e) mouse monoclonal anti-a-smooth muscle actin (aSMA), a marker for myofibroblasts, (f) mouse monoclonal anti-heat shock protein-47 (HSP-47, Stressgen, Victoria, BC, Canada), a collagen-binding stress protein and thought to be a collagen-specific molecular chaperone and a marker of collagen synthesis, (g) goat polyclonal anti-type III collagen (Southern Biotechnology, Birmingham, AL, USA), to evaluate the deposition of type III collagen, and (h) goat polyclonal anti-type I collagen (Southern Biotechnology), to evaluate the deposition of type I collagen, and (i) rat monoclonal anti-mouse F4/80 (AbDserotec, Oxford, UK), to evaluate the macrophage infiltration.
Immunohistochemistry for MMP-2 and MMP-9 as well as two-color immunohistochemistry for aSMA (Texas Red) and S100A4 (FITC) were performed using frozen tissue sections and standard indirect technique, followed by examination under a fluorescence microscope. For immunohistochemistry for S100A4, vimentin, aSMA, HSP-47, type III collagen, and type I collagen, formalin-fixed and paraffin-embedded tissue sections were used and the specimens were stained by the standard avidin-biotin-peroxidase complex technique. In order to optimize the detection of S100A4 and vimentin, sections were microwaved for 10 min in 0.01 M sodium citrate (pH 6.0) before incubation with the primary antibody. To detect HSP-47, type III collagen, and type I collagen, sections were incubated with 0.1% pepsin for 15 to 30 min before incubation with primary antibody.
For electron microscopic examination, the left kidney tissue was fixed in 2.5% glutaraldehyde solution in phosphate buffer (pH 7.4) and postfixed with 1% osmium tetroxide, dehydrated, and embedded in Epok 812. Ultrathin sections were stained with uranyl acetate and lead citrate, and then examined with an electron microscope (model H7100, Hitachi, Tokyo, Japan).
The area of Masson stain þ fibrosis and the expression of type III and type I collagens, S100A4, vimentin, aSMA, and HSP-47 was analyzed quantitatively using a computerassisted image analysis system comprising an Olympus BX60 microscope connected via a video camera to a PC. Data were analyzed using the WinROOF image processing software (Mitani, Tokyo, Japan). At least 20 digitized images of the renal cortex taken at Â 200 magnification (0.569 mm 2 ) were analyzed in each sample, and the percentage area of positive staining per field was evaluated.
Gelatin and In Situ Zymography Supernatant of 10 mg of total protein from the homogenate of the left kidney harvested from each animal was used for gelatin zymography, as described previously. 26 Briefly, electrophoresis was carried out on 10% polyacrylamide gels containing 0.1% gelatin under non-reducing conditions. After electrophoresis, the gels were washed in 2.5% Triton X-100 to remove sodium dodecyl sulfate, incubated for 16 h at 37 1C, and stained with 0.1% Coomassie Brilliant Blue R250 (Sigma). To test whether minocycline inhibits MMP-2 and MMP-9 activities, minocycline (0.5 or 10 mg/ml) was added to the rinse and reaction buffers during the development of the zymograms. MMP-2 and MMP-9 activities were estimated from their gelatinolytic activities. Densitometric analysis of the gels was performed using NIH image software (Image, v.1.62; National Institutes of Health, Bethesda, MD, USA). For mapping of gelatinolytic activity in the injured left kidney, in situ zymography was performed using the method described previously. 27 Gelatin-FITC films was prepared as described previously, 27 and cryostat-cut kidney sections (4-6 mm thickness) were placed on the film, and incubated at 37 1C for 6 to 32 h. After incubation, the films were examined under immunofluorescent microscope.
Real-Time PCR for EMT-Related Molecules
To examine the mRNA levels of the interstitial-type collagen, type III and type I collagens, the gelatinase-related molecules, MMP-2, MMP-9, TIMP-1, and TIMP-2, and the EMT-related molecules, integrin-linked kinase (ILK), transforming growth factor-b1 (TGF-b1), Smad 2, Wnt, b-catenin, Snail 1, and Snail 2, real-time PCR was performed using renal cortex tissues. The total RNA was extracted from the renal cortex by are compared with MMP-2 þ / þ mice.
ww Po0.001 is on MMP-2 þ / þ mice treated with minocycline, which is compared with MMP-2 À/À mice.
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Qiagen RNeasy Mini kit (Qiagen, Hilden, Germany). A cDNA copy was created with reverse transcriptase from High Capacity RT-kit (Applied Biosystems, Foster City, CA, USA). Gene expression was analyzed by real-time quantitative RT-PCR using the TaqMan system based on real-time detection of accumulated fluorescence according to the manual supplied by the manufacturer (ABI PRISM -7900HT; Applied Biosystems). The normalized value for mRNA expression in each sample was calculated as the relative quantity of relevant primers divided by the relative quantity of the housekeeping gene mouse GAPDH (4352339E). The sequences of the TaqMan sets were as follows: MMP-2 (Mm00439498_m1), MMP-9 (Mm00442991_m1), TIMP-1 (Mm00441818_m1), TIMP-2 (Mm00441825_m1), type I collagen, alpha 1 (Mm00801666_g1), type III collagen, alpha 1 (Mm01254476_
and Snail 2 (Mm00441531_m1). Quantification was performed using SDS 2.1 software.
Statistical Analysis
All data were expressed as mean±s.d. When multiple groups were analyzed simultaneously, the group comparison of one-way ANOVA (analysis of variance) with Tukey's HSD post hoc was used. If a Welch-ANOVA was conducted, Games-Howell method was applied. When two groups were analyzed, the unpaired Student's t-test was employed. Statistical significance was set at Po0.05. 
MMP-2 in renal fibrosis
þ / þ mice after UUO, renal tubular injury and interstitial fibrosis occurred by day 5, and developed at day 14 ( Figure 1) . Interstitial fibrosis at day 14 was characterized by the expansion of Masson stain þ fibrotic areas and the increased production and deposition of type III and type I collagens (Figures 1 and 2) . Together with or before the development of interstitial fibrosis, extensive tubular injury was noted with epithelial cell damage and loss of epithelial cell polarity. Analysis of MMP-2 and MMP-9 activities in the renal cortex using gelatin zymography (Figure 3) showed that UUO caused increased MMP-2 and MMP-9 activities in MMP-2 þ / þ mice at least at day 3. Subsequently, the activities of both MMP-2 and MMP-9 increased in a timedependent manner and reached highest levels at day 14, during the progression of interstitial fibrosis.
We also examined the expression of MMP-2 and MMP-9 in renal tissues in MMP-2 þ / þ mice before UUO and at day 14 post-UUO (Figure 4 ), when MMP activity was the highest during the development of interstitial fibrosis, as demonstrated on gelatin zymography. At baseline, MMP-2 and MMP-9 were not detected in the kidney. However, at day 14 post-UUO, the expression levels of MMP-2 and MMP-9 increased on damaged tubular epithelial cells in the dilated or atrophic damaged tubules.
In real-time PCR study, the production of MMP-2 and MMP-9 upregulated at day 14 post-UUO in MMP-2 þ / þ mice, although very low levels of these were noted before UUO or sham control mice. In addition, similar tendency of TIMP-1 and TIMP-2 production was seen before UUO and at day 14 post-UUO in MMP-2 þ / þ mice. Examination of MMP-2 and MMP-9 activities by in situ zymography in tissue sections showed gelatinase activity mainly in the dilated or atrophic renal tubules at day 14 ( Figure 5) , consistent with the expression of MMP-2 and MMP-9 in immunofluorescent study.
During the development of interstitial fibrosis, damaged tubular epithelial cells and interstitial cells exhibited mesenchymal and collage-producing phenotypes ( Figure 6 ). S100A4 þ , vimentin þ , aSMA þ , and HSP-47 þ tubular epithelial cells were occasionally present in damaged tubules ( Figure 7 ). In addition, only a very small number, but both S100A4 þ and aSMA þ myofibroblasts were noted in UUO in MMP-2 À/À Mice To clarify the role of MMP-2 in interstitial fibrogenesis, MMP-2 À/À mice were subjected to UUO. The kidneys of MMP-2 À/À mice showed minimal interstitial fibrosis with mild deposition of type III and type I collagens (Figures 1  and 2 ). Gelatin zymography and real-time PCR study confirmed the lack of production and activity of MMP-2 during the experiment (Figures 3 and 4) . MMP-9 activity increased by day 3, similar to MMP-2 þ / þ mice. From days 3 to 14 post-UUO, MMP-9 activity gradually increased, reaching a peak level at day 14 post-UUO. Comparison of MMP-2 À/À and MMP-2 þ / þ mice showed similar production and activity of MMP-9 at both baseline and post-UUO, and no upregulation of MMP-9 in MMP-2 À/À mice before and after UUO, compared with MMP-2 þ / þ mice. The in situ zymography demonstrated that gelatinase activity was also lower in MMP-2 À/À mice than MMP-2 þ / þ mice ( Figure 5 ), which may be associated with MMP-2 deficiency. During the development of fibrosis in MMP-2 À/À mice, the expression levels of S100A4, vimentin, HSP-47, and aSMA þ cells were less than the respective levels in MMP-2 þ / þ mice ( Figures  6-8 ), F4/80 þ macrophage infiltration was also inhibited in MMP-2 À/À mice. With regard to the EMT-related molecules, the upregulation of ILK, TGF-b/Smad, and Wnt/b-catenin signaling, and Snail was inhibited in MMP-2 À/À mice at day 14 ( Figure 9 ). Electron microscopy in MMP-2 À/À mice at day 14 showed loss of basolateral infolding and surface microvilli in tubular epithelial cells, the lack of spindle-shape epithelial cells and no clear changes in TBM (Figure 10) . Thus, the lack of MMP-2 reduced renal interstitial fibrosis post-UUO possibly through the suppression of tubular cell EMT, inhibition of myofibroblast accumulation, and suppression of macrophage infiltration.
UUO in MMP-2
þ / þ Mice Treated with Minocycline Finally, we examined the effects of MMP inhibitor on renal fibrosis by injecting minocycline in UUO-MMP-2 þ / þ mice. Minocycline reduced interstitial fibrosis at 14 days post-UUO, as determined by the Masson stain þ areas and the deposition of type III and type I collagens (Figures 1 and 2) . Minocycline inhibited the activities and the production of MMP-2 and MMP-9 ( Figures 3 and 4) . In addition, minocycline suppressed gelatinase activity in vivo ( Figure 5) . Minocycline reduced the expression of S100A4, vimentin, aSMA, and HSP-47 in the kidney at day 14 post-UUO (Figures 6-8 ). F4/80 þ macrophage infiltration was also inhibited by minocycline. With regard to EMT-related molecules, minocycline suppressed the upregulated expression of ILK, TGF-b/Smad, and Wnt/b-catenin signaling, and Snail at day 14 ( Figure 9 ). Electron microscopic examination of MMP-2 þ / þ mice treated with minocycline at day 14 showed minimal changes in tubular epithelial cells and TBM. In damaged tubules, basolateral in folding and surface microvilli of tubular epithelial cells were well preserved with mild changes in TBM (Figure 10 ). These results suggest that inhibition of MMP-2 and MMP-9 reduces interstitial fibrogenesis by possibly protecting EMT promotion and macrophage infiltration.
Importantly, the severity of the renal interstitial fibrosis including the deposition of type III and type I collagens, and the expression of S100A4, vimentin, aSMA, and HSP-47, was less prominent in MMP-2 À/À mice and MMP-2 þ / þ mice treated with minocycline than those in MMP-2 þ / þ mice. Furthermore, it was less prominent in MMP-2 þ / þ mice treated with minocycline than in MMP-2 À/À mice. These In recent years, EMT has attracted interest in the field of chronic renal diseases. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] Damaged tubular epithelial cells have mesenchymal phenotype through EMT, and migrate into interstitium. [7] [8] [9] [10] [11] [12] Indeed, one recent study using a gGTLacZ transgenic mice, which allows the indisputable identification of cells derived from proximal tubular epithelium in the kidney, reported that more than one-third of renal interstitial fibroblasts were derived from renal tubular epithelium through EMT. 28 MMP-2 and MMP-9, which mediate TBM degradation, are considered a critical event in renal EMT. 29, 30 MMP-2 appears both necessary and sufficient to induce tubular EMT. 19, 21 Similarly, a recent study using transgenic mice with targeted expression of active MMP-2 in the proximal tubular epithelial cells has demonstrated Figure 6 The expression of mesenchymal marker proteins, including S100A4 (a, f, k), vimentin (b, g, l), and a-smooth muscle actin (aSMA) (c, h, m), marker of collagen synthesis heat shock protein-47 (HSP-47), which is known as the collagen-specific molecular chaperone (d, i, n), and macrophage infiltration (F4/ 80) (e, j, o), at day 14 post-unilateral ureteral obstruction (UUO) in MMP-2 þ / þ mice (a-e: WT mice), MMP-2 À/À mice (f-j: MMP-2 KO mice), and MMP-2 þ / þ mice treated with minocycline (k-o: Minocycline) (a-o, Â 400). In MMP-2 þ / þ mice at day 14 post-UUO, the expression of S100A4, vimentin, aSMA, and HSP-47 was evident in damaged tubular epithelial cells and interstitial cells (arrowhead in panels a-d). Infiltration of macrophages was noted around tubules (arrowhead in panel e). However, they were less prominent in MMP-2 À/À mice and MMP-2 þ / þ mice treated with minocycline than those in
MMP-2 in renal fibrosis X Du et al directly that active MMP-2 alone is sufficient to drive the full spectrum of EMT. 21 Therefore, in addition to the pathogenic role of MMP-2 activity in the migration of tubular epithelial cells with mesenchymal phenotype into the interstitium accompanied by the destruction of TBM, recent studies have also indicated that MMP-2 can trigger EMT, probably through the disruption of TBM integrity.
Several current studies also indicate that EMT is unlikely to occur in vivo. [13] [14] [15] The comprehensive lineage tracing studies demonstrate that there is no evidence for EMT as a source of myofibroblasts in vivo in the kidney. [13] [14] [15] Rather, vascular pericytes or local interstitial fibroblasts are the source of fibrosis-generating myofibroblasts.
14,15 Our previous study of chronic rejection in renal transplantation model demonstrated that interstitial aSMA þ myofibroblasts initially occurred around peritubular capillaries and progressed into interstitium during the development of renal fibrosis. 31 Unfortunately, we did not analyze the pericytes around peritubular capillaries or local interstitial fibroblasts in detail in this study, because MMP-2 expressed mainly damaged renal tubular cells. In this study, we have considered that EMT may be involved in the fibrogenesis in the mice UUO model, although this is not the only mechanism, as (1) damaged tubular epithelial cells expressed mesenchymal and collagen production associated proteins, such as S100A4, vimentin, aSMA, and HSP47; (2) both aSMA þ and S100A4 þ myofibloblasts were present within renal tubules, although the number of these cells were only a few; (3) our electron microscopic findings indicated the spindle cells were present between renal tubules and interstitium through ruptured TBM; and (4) central mediator signalings of renal tubular cell EMT, such as ILK, TGF-b/Smad, Wnt/b-catenin, and Snail, were upregulated in the development of renal fibrosis.
Tubular epithelial cells are tightly connected with TBM via cell-ECM adhesion molecules such as integrin, and they are regulated microenvironment for their function. [32] [33] [34] [35] [36] In the cell-ECM interactions, integrin-mediated signals from the ECM are transduced by ILK, a cytoplasmic serine-threonine kinase, and the activated ILK upregulate the both b-catenin Figure 7 The expression of S100A4 (a, Â 800), vimentin (b, Â 800), a-smooth muscle actin (aSMA) (c, Â 800), and heat shock protein-47 (HSP-47, Â 800) (d) in renal tubules at day 14 post-unilateral ureteral obstruction (UUO), and double immunostaining with S100A4 (green) and aSMA (red) before UUO (e) and at day 14 post-UUO in MMP-2 þ / þ mice (f), MMP-2 À/À mice (g), and MMP-2 þ / þ mice treated with minocycline (h) (e-h, Â 600). S100A4 þ , vimentin þ , aSMA þ , or HSP-47 þ cells were present in damaged renal tubules (arrowhead in panels a-d). In addition, both S100A4 þ (green) and aSMA þ (red) myofibroblastic cells were present around tubules (arrowhead in panels e-h), and these cells were also present in renal tubules (arrow in panel f) at day 14 post-UUO in MMP-2 þ / þ mice.
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and Snail that is known as molecules involving EMT. [37] [38] [39] MMPs are involved in the regulation of cell-ECM interactions. 40 In addition, MMP-2 facilitates the production of active TGF-b1 protein, which is known as a key factor for EMT promotion. 19 In this study, UUO induced the production of ILK and b-catenin and upregulation of Snail. In addition, TGF-b1/Smad and Wnt/b-catenin signaling molecules, which are known as central mediator signaling of renal tubular cell EMT, were also upregulated during the process of renal fibrosis.
To examine the possible use of MMP inhibitors in the treatment of renal fibrosis, UUO was induced in MMP-2 À/À mice and in MMP-2 þ / þ mice treated with minocycline. Minocycline has a role in the inhibition of MMP-2 and MMP-9. 41 In this study, minocycline could inhibit activities and production of MMP-2 and MMP-9. The kidneys of MMP-2 in renal fibrosis X Du et al
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À/À and MMP-2 þ / þ mice treated with minocycline showed reduced EMT findings in tubular epithelial cells and preservation of renal fibrosis after UUO. Importantly, the ameliorative effects of minocycline on the severity of renal fibrosis were more pronounced than those of MMP-2 À/À mice. These results show that MMP-2 has an important role in the promotion of tubular cell EMT findings as well as the development of renal fibrosis. Furthermore, inhibition of MMP-2 and MMP-9 may be helpful in the restoration or maintenance of an epithelial phenotype, suppression of EMT findings, and inhibition of interstitial fibrosis.
Although inhibition of MMP-2 and MMP-9 mitigates tubular cell EMT findings, we have to consider also the possible role of the inflammatory cascade in the development of interstitial fibrosis after UUO. Macrophage MMP-9 mediates EMT in renal tubular cells. 42 MMP activity is usually linked to inflammation through interactions with and activation of several cytokines, chemokines and other pericellular and cell surface substrates. [43] [44] [45] Minocycline has broad anti-inflammatory properties, in addition to its action as an MMP inhibitor. 41 In this study, many F4/80 þ macrophages infiltrated around damaged tubules following UUO, which were suppressed in MMP-2 À/À mice or following treatment with minocycline. Thus, MMP-2 alone or MMP-2 and MMP-9 seem to enhance renal inflammation and contribute to the development of renal fibrosis.
In summary, the tubular epithelium, because of its unique mesenchymal origin, seems capable of acquiring mesenchymal phenotype in disease through EMT, and contributes to renal fibrosis in chronic renal diseases. This study demonstrated an important role for MMP-2 in the pathogenesis of renal fibrosis, that is, the probably induction and promotion of EMT findings. Induction of MMP-2 and targeted proteolysis of the TBM provides a unifying mechanism that MMP-2 in renal fibrosis X Du et al integrates the multiple pathophysiological processes that induce epithelial cell injury. Strategies aimed at inhibition of MMP-2 alone or MMP-2 and MMP-9, especially in the early stages of fibrosis, could reduce progressive fibrosis in chronic kidney diseases.
